Healthcare Global Enterprises balance sheet

As of Mar 2026

Total assets: ₹3,923cr+10.7% on Mar 2025
Shareholders' equity: ₹1,410cr+42.4% on Mar 2025
Total debt: ₹910cr−9.2% on Mar 2025
Cash and investments: ₹536cr+127.3% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	2,041	1,963	1,505	1,353
	18.6	24.8	83.2	18.2
	388	430	223	181
	32.9	48.9	29.9	18.7
	6.8	4.3	3.4	2.9
	7.1	7.0	7.0	6.8
	190	70.5	48.6	54.3
	197	77.5	55.6	61.1
	39.9	25.0	7.1	5.3
	63.5	126	120	95.3
	2,787	2,699	2,028	1,736
	59.8	53.0	42.7	38.3
	421	401	294	303
	536	236	273	175
	4.9	112	30.5	22.0
	3.4	2.7	1.9	1.8
	11.3	5.0	6.8	7.2
	976	756	606	508
	32.4	34.5	31.4	33.9
	1,069	844	680	580
	66.7	0.0	0.0	0.0
	3,923	3,543	2,708	2,316
Equity
	149	139	139	139
	1,183	783	686	721
	1,332	922	826	861
	78.2	67.6	39.3	8.9
	1,410	990	865	869
Liabilities
	599	605	485	362
	830	775	559	453
	1,429	1,380	1,044	815
	25.3	21.4	15.7	13.2
	2.3	3.5	6.1	12.4
	38.5	102	32.8	35.9
	1,495	1,507	1,099	876
	311	398	187	37.6
	351	334	281	248
	255	256	206	189
	917	988	675	475
	23.4	19.4	18.3	17.1
	3.6	2.6	2.2	2.5
	38.8	36.7	48.3	75.5
	983	1,046	744	570
	34.4	—	0.0	0.0
	2,512	2,553	1,842	1,447
	3,923	3,543	2,708	2,316
Trade payables — MSME split
	5.6	4.1	—	—
	345	330	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

HCG₹591.45

Healthcare Global Enterprises Ltd.

· Pharma & Health

₹ CrorePeersAPOLLOHOSP FORTIS RAINBOW JLHL CORONA MARKSANS METROPOLIS PARKHOSPSMcap ₹8,511 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	1,353.1	1,505.4	1,963.0	2,041.2	2,041.2
+ Capital Work-in-Progress	18.2	83.2	24.8	18.6	18.6
+ Goodwill	181.2	222.9	430.0	387.6	387.6
+ Other Intangibles	18.7	29.9	48.9	32.9	32.9
+ Investments (Equity Method)	2.9	3.4	4.3	6.8	6.8
+ Non-current Investments	6.8	7.0	7.0	7.1	7.1
+ Other Non-current Financial Assets	54.3	48.6	70.5	189.8	189.8
Non-current Financial Assets	61.1	55.6	77.5	196.9	196.9
+ Deferred Tax Assets	5.3	7.1	25.0	39.9	39.9
+ Other Non-current Assets	95.3	120.3	126.0	63.5	63.5
Total Non-current Assets	1,735.7	2,027.7	2,699.4	2,787.3	2,787.3
Current Assets
+ Inventories	38.3	42.7	53.0	59.8	59.8
+ Trade Receivables	302.5	294.0	400.9	420.7	420.7
+ Cash & Cash Equivalents	174.6	272.6	235.9	536.1	536.1
+ Other Bank Balances	22.0	30.5	111.8	4.9	4.9
+ Short-term Loans	1.8	1.9	2.7	3.4	3.4
+ Other Current Financial Assets	7.2	6.8	5.0	11.3	11.3
Current Financial Assets	508.1	605.8	756.3	976.3	976.3
+ Other Current Assets	33.9	31.4	34.5	32.4	32.4
Total Current Assets	580.3	679.9	843.8	1,068.5	1,068.5
+ Assets Held for Sale	0.0	0.0	0.0	66.7	66.7
Total Assets	2,316.0	2,707.5	3,543.2	3,922.5	3,922.5
Equity
+ Equity Share Capital	139.1	139.3	139.4	149.3	149.3
+ Other Equity / Reserves	721.4	686.5	783.0	1,182.7	1,182.7
Equity — Owners of Parent	860.5	825.8	922.5	1,332.0	1,332.0
+ Minority Interest	8.9	39.3	67.6	78.2	78.2
Total Equity	869.4	865.1	990.1	1,410.2	1,410.2
Liabilities
+ Borrowings — Non-current	361.7	485.3	604.6	599.2	599.2
+ Other Non-current Financial Liab	453.1	558.8	775.1	829.9	829.9
Non-current Financial Liabilities	814.8	1,044.1	1,379.7	1,429.1	1,429.1
+ Provisions — Non-current	13.2	15.7	21.4	25.3	25.3
+ Deferred Tax Liabilities	12.4	6.1	3.5	2.3	2.3
+ Other Non-current Liabilities	35.9	32.8	102.1	38.5	38.5
Non-current Liabilities	876.3	1,098.7	1,506.8	1,495.2	1,495.2
+ Borrowings — Current	37.6	187.5	397.7	311.2	311.2
+ Trade Payables	248.5	281.1	334.3	351.0	351.0
+ Other Current Financial Liab	189.2	206.4	255.8	254.6	254.6
Current Financial Liabilities	475.2	675.0	987.7	916.9	916.9
+ Provisions — Current	17.1	18.3	19.4	23.4	23.4
+ Current Tax Liabilities	2.5	2.2	2.6	3.6	3.6
+ Other Current Liabilities	75.5	48.3	36.7	38.8	38.8
Current Liabilities	570.3	743.7	1,046.4	982.7	982.7
+ Liabilities Held for Sale	0.0	0.0	—	34.4	34.4
Total Liabilities	1,446.6	1,842.4	2,553.2	2,512.3	2,512.3
Total Equity & Liabilities	2,316.0	2,707.5	3,543.2	3,922.5	3,922.5
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	4.1	5.6	5.6
+ Dues to Other Creditors — Current	—	—	330.1	345.5	345.5

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.